Dr. Jart+ Ctrl-A Teatreement Soothing Spot 15ml
This item is currently out of stock
Get notified when it's back in stock
Shoppers Also Loved:
Product Description
Dr. Jart+ Ctrl-A Teatreement Soothing Spot offers a targeted solution for those pesky blemishes. This distinctive pink liquid helps to calm existing spots while working proactively to prevent new ones from appearing. Its chalky texture allows for easy application, making it a handy addition to your skincare routine.
Formulated with a 9.9% Calamine concentration, it effectively controls excess oily sebum that can contribute to breakouts. The inclusion of the Teatreetment™ solution, which contains Australian Tea Tree Leaf, adds a purifying touch designed to keep skin feeling refreshed and balanced throughout the day.
Additionally, Niacinamide works to improve skin clarity, helping your complexion look smoother and more even over time. Dermatologist tested for both safety and effectiveness, Dr. Jart+ Ctrl-A Teatreement Soothing Spot combines thoughtful ingredients in one convenient treatment to support clearer skin.
Product details
Ingredient Highlights: Contains tea tree oil.
Good to know: Dermatologically tested.
Made In: South Korea
Ingredient Features
This Dr. Jart+ skin treatment product works to sooth inflamed skin and to reduce redness as it contains tea tree oil.
Can you message me when this Dr. Jart+ product is available again?
We can notify you when it’s back in stock, simply sign up at the top of the page.
Are Dr. Jart+ a Dermatologist recommended Skin Care brand?
This Skin Care item from Dr. Jart+ is recommended by Dermatologists.
Delivery & Returns
Products over £72.00 qualify for free standard delivery with Care to Beauty, otherwise there is a charge of £5.07 with orders usually arriving within 1-5 days of dispatch. Express/Next day delivery option available. Worldwide delivery generally available, delivery costs vary by region, full list and postage costs available during checkout.
The returns policy for this retailer is around 15 days, see their website for further information.
